Efek Konseling Apoteker Terhadap Kepatuhan Minum Obat dan Kualitas Hidup Penderita Skizofrenia di Rumah Sakit Jiwa Menur Surabaya

Verra Yuliana, Adji P. Setiadi, Josephine P. Ayuningtyas

Abstract


Skizofrenia merupakan gangguan psikiatri yang kompleks ditandai dengan gangguan kognitif, emosi, persepsi, berpikir dan berperilaku. Penelitian ini dilakukan untuk mengetahui perbedaan tingkat kepatuhan minum obat pasien skizofrenia sebelum dan setelah diberikan konseling oleh apoteker serta untuk mengetahui kualitas hidupnya. Metode penelitian ini adalah one-grup pretest-posttest yang bersifat prospektif. Pengambilan sampel terhadap responden sesuai kriteria inklusi dilakukan di Instalasi Farmasi Rumah Sakit Jiwa Menur pada bulan Mei sampai Juli tahun 2018. Sebelum pengambilan data dilakukan, responden yang sesuai dengan kriteria inklusi diberikan penjelasan tentang tujuan dan gambaran penelitian. Apabila setuju menjadi subjek, pasien atau keluarganya diwajibkan mengisi informed consent. Wawancara sesuai kuesioner Medication Adherence Rating Score (MARS) dan The World Health Organization Quality of Life (WHOQOL)-BREF pada responden dilakukan dua kali, yakni pada kedatangan pertama sebelum dilakukan konseling dan satu bulan kemudian saat subjek kontrol kembali. Total responden sebanyak 100 orang. Data dianalisis menggunakan uji beda (uji T). Hasil penelitian menunjukkan terdapat perbedaan bermakna pada kepatuhan minum obat responden antara pre-post konseling oleh apoteker (p=0,033). Hasil penelitian ini menunjukkan bahwa kualitas hidup subjek memiliki perbedaan bermakna hanya terkait domain lingkungan (p=0,00), sedangkan pada domain fisik, mental dan sosial tidak memiliki perbedaan bermakna (p>0,05).

Kata kunci: Kepatuhan, kualitas hidup, MARS, skizofrenia, WHOQOL-BREF

 

Effect of Pharmacist Counseling on Medication Adherence and Quality of Life of Schizophrenic Patients in Menur Mental Hospital, Surabaya

Abstract
Schizophrenia is a complex psychiatric disorder characterized by cognitive, emotion, perception, thinking, and behavior impairment. This research was conducted to determine the difference in level of compliance with schizophrenic patients before and after counseling by pharmacist, as well as to know their quality of life. The research method was one-group pretest-posttest with perspective design. Sampling of samples who met the inclusion criteria was done in the pharmaceutical installation of Menur Psychiatric Hospital from May to July 2018. Before data retrieval was done, all samples appropriated with the inclusion criteria were given an explanation about the purpose and description of the study, and after agreeing to be the subject, the patients or their family were obliged to fill informed consent. Interviews according to the Medication Adherence Rating Score (MARS) dan The World Health Organization Quality of Life (WHOQOL)-BREF questionnaires were done twice; the first was done upon arrival before counseling and the later was one month upon returning for control. Total of subjects was 100 people. The obtained data was analyzed using a different test (t-test). The result showed that there was a meaningful difference in patients’ compliance in taking drugs between pre and post counseling by the pharmacist (p=0.033). In terms of patients’ quality of life, results showed that the meaningful difference were only related to environmental domain (p=0.00), whereas no meaningful differences found on physical, mental and social domains (p>0.05).

Keywords: Adherence, MARS, quality of life, schizophrenia, WHOQOL-BREF


Keywords


Kepatuhan; Kualitas Hidup; MARS; Skizofrenia; WHOQOL-BREF.

References


Kementerian Kesehatan Republik Indonesia. Undang-undang Republik Indonesia Nomor 18 Tahun 2014 Tentang Kesehatan Jiwa. Jakarta: Kementerian Kesehatan Republik Indonesia; 2014.

Barbato A. Schizophrenia and public health. Nations for mental health. Geneva: World Health Organization; 1998.

Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar Tahun 2013. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.

Suzuki T, Uchida H, Takeuchi H, Tsuboi T, Hirano J, Mimura M. A review on schizophrenia and relapse—a quest for user-friendly psychopharmacotherapy. Hum Psychopharm Clin. 2014;29(5):414–26. doi: 10.1002/hup.2421

Tarutani S, Kikuyama H, Ohta M, Kanazawa T, Okamura T, Yoneda H. Association between medication adherence and duration of outpatient treatment in patients with schizophrenia. Psychiatry Investig. 2016;13(4):413–9. doi: 10.4306/pi.2016.13.4.413

Salazar-Ospina A, Amariles P, Benjumea DM, Gutierrez F, Faus MJ, et al. Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: Study protocol for a randomized controlled trial. Trials. 2014;15(52):1–10. doi: 10.1186/1745-6215-15-174

Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: A narrative review. Int J Environ Res Public Health. 2014;11(3):10967–90. doi: 10.3390/ijerph111010967.

Rickles NM, Dube GL, Mccarter A, Olshan JS. Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc. 2010;50(6):704–13. doi: 10.1331/JAPhA.2010.09042

Dhubhlaing CN, Young A, Sahm LJ. Impact of pharmacist counselling on clozapine knowledge. Schizophr Res Treatment. 2017;2017:6120970.

Reilly CLO, Bell JS, Kelly PJ, Chen TF. Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Res Soc Adm Pharm. 2015;11(3):e101–9. doi: 10.1016/j.sapharm.2013.04.006.

Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, et al. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011;37(4):727–36. doi: 10.1093/schbul/sbp121.

Panesar K. Barriers to counseling patients with mental health disorders. US Pharm. 2016;41(11):30–3.

Aaltonen SE, Laine NP, Volmer D, Gharat MS, Muceniece R, Vitola A, et al. Barriers to medication counselling for people with mental health disorders: A six country study. Pharm Pract. 2010;8(2):122–31.

Barkhof E, Meijer CJ, Sonneville LMJ De, Linszen DH, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr Bull. 2013;39(6):1242–51. doi: 10.1093/schbul/sbt138.

Naafi A, Perwitasari DA, Darmawan E. Medication adherence of schizophrenia outpatients in Prof. Dr. Soerojo Mental Hospital Magelang. Kartika J Ilm Farm. 2016;4(2):7–12. doi: 10.26874/kjif.v4i2.60

World Health Organization. The World Health Organization Quality of Life (WHOQOL)-BREF; 2004.

Mishra A, Krishna GS, Sravani A, Kurian TD, Kurian J, Ramesh M, et al. Impact of pharmacist-led collaborative patient education on medication adherence and quality of life of schizophrenia patients in a tertiary care setting. Bull Fac Pharmacy, Cairo Univ. 2017;55(2):345–9. doi: 10.1016/j.bfopcu.2017.08.001

Gomes E, Bastos T, Probst M, Riberio JC, Silva G, Corredeira R. Quality of life and physical activity levels in outpatients with schizophrenia. Braz J Psychiatry. 2016;38(2):157–60. doi: 10.1590/1516-4446-2015-1709.

Sadock BJ, Sadock VA. Kaplan and sadock’s pocket handbook of clinical psychiatry, 5th Edition. USA: Wolters Kluwer Health, Lippincont Williams & Wilkins; 2010.

Mohandoss AA. Quality of life in schizophrenic patients: Comparative study from South India. J Dr NTR Univ Heal Sci. 2017;6(4):224–31. doi: 10.4103/2277-8632.221523

Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: How important are symptoms and functioning? Int J Ment Health Syst. 2010;4:31. doi: 10.1186/1752-4458-4-31.




DOI: https://doi.org/10.15416/ijcp.2019.8.3.196

Refbacks

  • There are currently no refbacks.


 Indonesian Journal of Clinical Pharmacy is indexed by

        

  Creative Commons License

IJCP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 

View My Stats